19 Jul 2007 Orchestra Therapeutics discontinues its HIV vaccine development program
19 Jul 2007 Publication of VIR201 Phase IIa trial results in peer reviewed scientific journal
19 Jul 2007 TechnoVax Reports on a VLP Vaccine Designed to Protect Against the Devastating 1918 Pandemic Influenza As Well As a Novel Bivalent VLP Vaccine Candidate
18 Jul 2007 Acambis' universal influenza vaccine enters Phase 1 trial
18 Jul 2007 GeoVax Announces Start of 2 New HIV/AIDS Vaccine Human Trials
13 Jul 2007 Dynavax Completes Enrollment of HEPLISAV(TM) Phase 3
12 Jul 2007 Geron initiates clinical trial of Telomerase cancer vaccine in patients with acute myelogenous leukemia
12 Jul 2007 Clinical Development Update
11 Jul 2007 Cell Genesys Completes Patient Recruitment for First Phase 3 Clinical Trial of GVAX Immunotherapy for Prostate Cancer
10 Jul 2007 Novavax Licenses Wyeth's Virus-Like Particle Technology
04 Jul 2007 Cytos Biotechnology reports results from phase IIa study with CYT003-QbG10 in patients suffering from atopic dermatitis
04 Jul 2007 MedImmune Begins Dosing Children Six Months to 24 Months of Age in Phase 1 Study of Vaccine to Help Prevent Two of the Most Common Viral Causes of Childhood Respiratory Illness
03 Jul 2007 Novartis enhances its vaccine pipeline by gaining access to Intercell's key technologies and vaccines programs
03 Jul 2007 DOR BioPharma Announces Publication Describing Results of Its Multivalent Botulinum Toxin Vaccine BT-VACC(TM)
28 Jun 2007 AVANT's Partner, GlaxoSmithKline, Files Rotarix(R) Application for U.S. Marketing Approval with the FDA
27 Jun 2007 Dynavax Starts HEPLISAV(TM) Phase 3 in Europe; U.S. Study; and Phase 2 in ESRD in Canada
22 Jun 2007 Opexa Therapeutics Reports Positive Top-line Data in Phase I/II Extension Trial with Tovaxin(TM) for Multiple Sclerosis
22 Jun 2007 First ad35-based HIV-1 vaccine enters Phase I clinical trial at the NIH
19 Jun 2007 Diamyd diabetes study invalidated
19 Jun 2007 Phase I for Influenza vaccine adjuvanted with Intercell’s IC31(TM) started
19 Jun 2007 New Flu Vaccine From PepTcell Could Provide Immunity Against All Strains of Influenza Virus
18 Jun 2007 Hypertension vaccine CYT006-AngQb achieves strong blood
14 Jun 2007 Novartis gains European approval for its innovative flu vaccine Optaflu(R)
14 Jun 2007 GlaxoSmithKline's application for DTaP-IPV vaccine is accepted for review by the FDA
12 Jun 2007 Opexa Presents Tovaxin(TM) Research at Federation of Clinical Immunology Societies Annual Meeting

La Merie Biologics

FREE Weekly News Bulletin

Sign Up

2017 Sales ofAntibodies & Proteins

New Product Alert

For La Merie Publishing

Sign Up